Jonkers IJ - Search Results

1

Treatment failure in Haemophilus influenzae due to a beta-lactamase low-level ampicillin-resistant organism.

van der Ploeg V, Gelinck LB, Jonkers IJ, Mourer JS, van Dam AP. van der Ploeg V, et al. Among authors: jonkers ij. J Infect. 2008 Dec;57(6):485-8. doi: 10.1016/j.jinf.2008.06.024. Epub 2008 Sep 5. J Infect. 2008. PMID: 18775568

2

Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.

Jonkers IJ, Smelt AH, Princen HM, Kuipers F, Romijn JA, Boverhof R, Masclee AA, Stellaard F. Jonkers IJ, et al. J Nutr. 2006 Apr;136(4):987-91. doi: 10.1093/jn/136.4.987. J Nutr. 2006. PMID: 16549462 Free article. Clinical Trial.

3

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.

Jonkers IJ, Mohrschladt MF, Westendorp RG, van der Laarse A, Smelt AH. Jonkers IJ, et al. Am J Med. 2002 Mar;112(4):275-80. doi: 10.1016/s0002-9343(01)01123-8. Am J Med. 2002. PMID: 11893366 Clinical Trial.

4

Hypertriglyceridemia: associated risks and effect of drug treatment.

Jonkers IJ, Smelt AH, van der Laarse A. Jonkers IJ, et al. Am J Cardiovasc Drugs. 2001;1(6):455-66. doi: 10.2165/00129784-200101060-00005. Am J Cardiovasc Drugs. 2001. PMID: 14728004 Review.

5

Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia.

Jonkers IJ, van de Ree MA, Smelt AH, de Man FH, Jansen H, Meinders AE, van der Laarse A, Blauw GJ. Jonkers IJ, et al. Cardiovasc Res. 2002 Feb 1;53(2):496-501. doi: 10.1016/s0008-6363(01)00504-1. Cardiovasc Res. 2002. PMID: 11827701

6

Modulating effect of the A-278C promoter polymorphism in the cholesterol 7alpha-hydroxylase gene on serum lipid levels in normolipidaemic and hypertriglyceridaemic individuals.

Hofman MK, Groenendijk M, Verkuijlen PJ, Jonkers IJ, Mohrschladt MF, Smelt AH, Princen HM. Hofman MK, et al. Among authors: jonkers ij. Eur J Hum Genet. 2004 Nov;12(11):935-41. doi: 10.1038/sj.ejhg.5201236. Eur J Hum Genet. 2004. PMID: 15241483

7

Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.

de Man FH, Jonkers IJ, Schwedhelm E, Smelt AH, Onkenhout W, van Duyvenvoorde W, Buytenhek R, Leuven JA, Troost R, van Der Laarse A, Princen HM. de Man FH, et al. Among authors: jonkers ij. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2434-40. doi: 10.1161/01.atv.20.11.2434. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073849 Clinical Trial.

8

Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia.

Jonkers IJ, de Man FH, van der Laarse A, Frölich M, Gevers Leuven JA, Kamper AM, Blauw GJ, Smelt AH. Jonkers IJ, et al. J Hypertens. 2001 Apr;19(4):749-55. doi: 10.1097/00004872-200104000-00012. J Hypertens. 2001. PMID: 11330878 Clinical Trial.

9

Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy.

Jonkers IJ, de Man FH, van Tilburg NH, van der Laarse A, Sandset PM, Smelt AH, Bertina RM. Jonkers IJ, et al. Blood Coagul Fibrinolysis. 2001 Dec;12(8):705-12. doi: 10.1097/00001721-200112000-00013. Blood Coagul Fibrinolysis. 2001. PMID: 11734672 Clinical Trial.

10

Effects of very long chain versus long chain triglycerides on gastrointestinal motility and hormone release in humans.

Jonkers IJ, Ledeboer M, Steens J, Smelt AH, Masclee AA. Jonkers IJ, et al. Dig Dis Sci. 2000 Sep;45(9):1719-26. doi: 10.1023/a:1005594514399. Dig Dis Sci. 2000. PMID: 11052310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters